Hualan Bio/Jokes Record Learning Sticker Pharmaceutical Stock is the same as Technology Stock. All belong to the sea of stars. But. Who belongs to that star. You don't know. So. The best option is to buy

Hualan Bio/Jokes Record Learning Stickers

Pharmaceutical stocks are the same as technology stocks. All belong to the sea of stars.

But. Who belongs to that star. You don't know.

So. The best option is to buy the index.

Pharmaceutical ETFs. and medical ETFs. Very good.

China-wide Interconnection ETF. Very good.

And the money. In fact, it should start to get excited now.

Buffett has said he won't buy pharmaceutical stocks.

None of his successful investments were pharmaceutical stocks.

At the 1999 Berkshire shareholder meeting, a shareholder asked Buffett: In 1993, when pharmaceutical stocks fell sharply, you did not take the opportunity to buy shares of major pharmaceutical companies at a low price, was it a big mistake? Buffett replied: "It's just too bad that I didn't do that." If there is another opportunity like this, I will react in a second and buy a basket of large pharmaceutical stocks at a price below the average price-to-earnings level of the market. Buffett's investment logic is simple: major pharmaceutical companies have a competitive advantage and long-term sustainability. Buffett also said: "I would not try to pick a single pharmaceutical company stock worth investing in, because it is too difficult to pick the final winner in the pharmaceutical industry, so I would rather buy a basket of major pharmaceutical companies at the same time."

So why doesn't Buffett buy pharmaceutical stocks? Because pharmaceutical stocks are as risky as film and television stocks, the initial investment is huge, success or failure in this move, investment is not a gamble, so the stock god is not optimistic.

On the other hand, the risk of pharmaceutical stocks is better than that of cyclical stocks: a collection of news, a clinical data is not ideal, it may cause secondary market stocks to fall to a halt, so the PN ratio of pharmaceutical stocks should be less than ten times as a risk compensation. On the other hand, the US stock market is very rational about pharmaceutical stocks, and Pfizer's bull stock rose by 65% last year, and the price-earnings ratio was only 15.27 times.

remark. But. Apple in tech stocks is different.

This is evolution. Apple evolved into a consumer stock.

Because of the certainty that is available over a long period of time.